KELSIE HANNAH: Open Payments
NPI 1033701057 · ASHLAND CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,587 in 77 payments from 16 companies in 2025. Trend: 2023 $764 · 2024 $1,537 · 2025 $1,587
Food & beverage: $1,553Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $384 |
| CSL Behring | 9 | $221 |
| GlaxoSmithKline, LLC. | 14 | $219 |
| GENZYME CORPORATION | 9 | $207 |
| Amgen Inc. | 5 | $115 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Grifols USA, LLC | 2 | $37 |
| Cycle Pharmaceuticals Inc | 1 | $27 |
Products named: DUPIXENT, NUCALA, FASENRA, Andembry, TEZSPIRE, NEFFY, AIRSUPRA, EOHILIA.
Industry payments across TN — which companies pay providers there.
